Sectoral Asset Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Sectoral Asset Management’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-69,164	Closed	-$952K	–	73
2019 Q3	$952K	Hold	69,164	–	–	0.16%	61
2019 Q2	$1.02M	Hold	69,164	–	–	0.12%	68
2019 Q1	$2.9M	Buy	69,164 +6,250	+10%	+$263K	0.35%	64
2018 Q4	$2.62M	Sell	62,914 -10,000	-14%	-$450K	0.36%	57
2018 Q3	$3.51M	Buy	72,914 +40,000	+122%	+$2M	0.37%	60
2018 Q2	$1.56M	Hold	32,914	–	–	0.17%	62
2018 Q1	$2.02M	Buy	32,914 +2,068	+7%	+$109K	0.22%	63
2017 Q4	$1.66M	Hold	30,846	–	–	0.21%	60
2017 Q3	$2.08M	Buy	30,846 +2,721	+10%	+$156K	0.27%	54
2017 Q2	$1.52M	Buy	+28,125	New	+$1.3M	0.17%	54

Other funds holding FSTX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sectoral Asset Management's FSTX Position: Q4 2019 in Review

Sectoral Asset Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q4 2019, closing a stake of 69,164 shares — an estimated $952K sold.

Sectoral Asset Management first reported a position in FSTX in Q2 2017 and held it in 10 quarters. The position peaked at $3.51M in Q3 2018. 31 funds tracked by Wall St. Rank hold FSTX as of Q4 2019.

Sectoral Asset Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Sectoral Asset Management sold 69,164 F-star Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $952K.
Sectoral Asset Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2017 and held it in 10 quarters.
Sectoral Asset Management's F-star Therapeutics, Inc. Common Stock position peaked at $3.51M in Q3 2018.
31 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Sectoral Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.